Article Information
History
- November 13, 2020.
Article Versions
- You are currently viewing Version 1 of this article (November 13, 2020 - 01:58).
- Version 2 (December 24, 2020 - 09:12).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Antonin Bal*,1,2,
- Gregory Destras*,1,2,
- Alexandre Gaymard*,1,2,
- Hadrien Regue1,
- Quentin Semanas1,
- Constance d’Aubarde3,
- Geneviève Billaud1,2,
- Frédéric Laurent4,5,
- Claudia Gonzales1,
- Martine Valette1,
- Bruno Lina1,2,
- Florence Morfin1,2,
- Laurence Josset1,2,#,
- the COVID-Diagnosis HCL Study Group
- 1Laboratoire de Virologie, Institut des Agents Infectieux, Laboratoire associé au Centre National de Référence des virus des infections respiratoires, Hospices Civils de Lyon, Lyon, France
- 2CIRI, Centre International de Recherche en Infectiologie, Team VirPath, Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, F-69007, Lyon, France
- 3Occupational Health and Medicine Department, Hospices Civils de Lyon, Lyon, France
- 4CIRI - Centre International de Recherche en Infectiologie, Team Pathogenesis of staphylococcal infections Inserm U1111, CNRS UMR5308, ENS Lyon, Université Claude Bernard Lyon 1, Lyon, France
- 5Laboratoire de Bactériologie, Institut des Agents Infectieux, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France
- ↵#Corresponding author:
Laurence Josset, Pharm.D, Ph.D, Associate Professor, Lyon 1 University, Hospices Civils de Lyon, France, National reference center for respiratory viruses, Phone: +33 (0)4 72 12 96 47, Email: laurence.josset{at}chu-lyon.fr
↵* equal contribution
Posted November 13, 2020.
Screening of the H69 and V70 deletions in the SARS-CoV-2 spike protein with a RT-PCR diagnosis assay reveals low prevalence in Lyon, France
